These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4418806)

  • 21. [Blood component therapy (author's transl)].
    Kretschmer V
    Anasth Intensivther Notfallmed; 1980 Jun; 15(3):189-200. PubMed ID: 7468950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Supportive treatment in hemopathies].
    Juliá Font A
    Sangre (Barc); 1984; 29(4-C):668-73. PubMed ID: 6440299
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic problems after massive blood transfusions].
    Wendt M; Lawin P; Götz E
    Infusionsther Klin Ernahr; 1979 Dec; 6(6):325-9. PubMed ID: 396253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood transfusion and transfusion reactions.
    Bechtoldt AA
    J Am Assoc Nurse Anesth; 1969 Dec; 37(6):450-9. PubMed ID: 5196267
    [No Abstract]   [Full Text] [Related]  

  • 25. [Blood plasma fractions in the management of coagulation disorders. I. Fibrinogen substitution].
    Richter K
    Z Gesamte Inn Med; 1967 May; 22(10):296-9. PubMed ID: 5586060
    [No Abstract]   [Full Text] [Related]  

  • 26. [Indications of the different components of blood and outcome of transfusion practices in postpartum hemorrhage].
    Ricat R; Palot M
    Cah Anesthesiol; 1994; 42(3):385-9. PubMed ID: 7812867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Replacing the administration of whole blood with blood derivatives].
    Baklaja R
    Bilt Hematol Transfuz; 1982; 10(2-3):115-29. PubMed ID: 6927292
    [No Abstract]   [Full Text] [Related]  

  • 28. Anaemia and massive bleeding apart from the aspect of oxygenation.
    Zander R
    Wien Klin Wochenschr; 2010 Dec; 122 Suppl 5():S6-8. PubMed ID: 21598437
    [No Abstract]   [Full Text] [Related]  

  • 29. [Indication for fresh blood transfusion].
    Seidl S
    Dtsch Med Wochenschr; 1969 Feb; 94(8):388-90. PubMed ID: 5763801
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of blood products and factor concentrates for coagulation therapy.
    Fritsma MG
    Clin Lab Sci; 2003; 16(2):115-9. PubMed ID: 12757192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfusion support in acquired coagulation disorders.
    Phillips LL
    Clin Haematol; 1984 Feb; 13(1):137-50. PubMed ID: 6723119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Status of "blood coagulation active human citrate plasma" within the scope of blood component therapy].
    Wegener S; Wilms K; Schlaack P; Roewer J
    Z Arztl Fortbild (Jena); 1987; 81(22):1151-4. PubMed ID: 3328435
    [No Abstract]   [Full Text] [Related]  

  • 33. [Massive transfusions: technical problems and complications].
    Vignon H
    Ann Anesthesiol Fr; 1975 Sep; 16(5):1I-8I. PubMed ID: 7159
    [No Abstract]   [Full Text] [Related]  

  • 34. [Transfusion therapy of blood coagulation disorders].
    Nenci GG
    G Clin Med; 1974 Jul; 55(7):457-67. PubMed ID: 4466706
    [No Abstract]   [Full Text] [Related]  

  • 35. [Substitution therapy of coagulopathies].
    Beeser H; Egli H
    Infusionstherapie (1973); 1974 Aug; 1(6):447-53. PubMed ID: 4466806
    [No Abstract]   [Full Text] [Related]  

  • 36. Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies.
    de Alarcon P; Benjamin R; Dugdale M; Kessler C; Shopnick R; Smith P; Abshire T; Hambleton J; Matthew P; Ortiz I; Cohen A; Konkle BA; Streiff M; Lee M; Wages D; Corash L
    Transfusion; 2005 Aug; 45(8):1362-72. PubMed ID: 16078927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Massive blood transfusion therapy.
    Corazza ML; Hranchook AM
    AANA J; 2000 Aug; 68(4):311-4. PubMed ID: 11125603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostics and therapy of hemolytic-hemorrhagic transfusion incidents].
    Brüster H
    Zentralbl Neurochir; 1972; 33(1):63-8. PubMed ID: 5072151
    [No Abstract]   [Full Text] [Related]  

  • 39. [Letter: Stored blood or concentrate of erythrocytes?].
    Spielmann W
    Dtsch Med Wochenschr; 1974 Feb; 99(8):372. PubMed ID: 4822444
    [No Abstract]   [Full Text] [Related]  

  • 40. [Duration of life of the fibrin stabilizing factor (factor 13). Therapeutic indications].
    Josso F; Petrova M; Ménaché D; Sizonenko P
    Transfusion (Paris); 1966; 9(4):343-6. PubMed ID: 5966234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.